Raymond James Cuts DRI Healthcare Trust (TSE:DHT.UN) Price Target to C$22.00

DRI Healthcare Trust (TSE:DHT.UN) had its price target cut by Raymond James from C$23.00 to C$22.00 in a research note published on Wednesday,BayStreet.CA reports.

A number of other equities analysts have also weighed in on the company. Truist Financial decreased their target price on DRI Healthcare Trust from C$17.00 to C$14.00 in a research note on Thursday, July 25th. Scotiabank boosted their price objective on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, DRI Healthcare Trust has a consensus rating of “Moderate Buy” and a consensus target price of C$18.00.

DRI Healthcare Trust Price Performance

Shares of DRI Healthcare Trust stock opened at C$12.94 on Wednesday. The company’s 50-day moving average price is C$13.32 and its 200-day moving average price is C$13.61. DRI Healthcare Trust has a 12-month low of C$10.39 and a 12-month high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were given a $0.085 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a yield of 2.63%. DRI Healthcare Trust’s payout ratio is -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.